In conclusion, we have demonstrated that novel intravenously administered lactoferrin- and lactoferricin-bearing DAB dendriplexes resulted in an improved tumor gene expression, while decreasing non-specific gene expression in the liver. This evidence concerns the gene LTF and neoplasm.